Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.78 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.78 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | LDHA | P00338 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sucrose SCHEMBL28123662 | 0.98 | CDK1 (0.80) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL20769817 | 0.98 | CDK1 (0.80) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL106974 | 0.98 | CDK1 (0.80) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL2905150 | 0.98 | CDK1 (0.80) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL1006530 | 0.97 | CDK1 (0.78) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL23549940 | 0.97 | CDK1 (0.82) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL25403460 | 0.97 | CDK1 (0.82) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL24274201 | 0.97 | CDK1 (0.82) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL24202550 | 0.97 | CDK1 (0.82) | CDK1CCNB1CA2CA9MEN1 | |
| Sucrose SCHEMBL21907913 | 0.97 | CDK1 (0.82) | CDK1CCNB1CA2CA9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230008240-A1 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | AMERICAN REGENT, INC. (US) | 2023-01-12 | — | — | US | disclosed |
| US-11364260-B2 | Methods and compositions for administration of iron | AMERICAN REGENT, INC. (US) | 2022-06-21 | — | — | US | disclosed |
| US-11344568-B2 | Methods and compositions for administration of iron | AMERICAN REGENT, INC. (US) | 2022-05-31 | — | — | US | disclosed |
| US-20200215096-A1 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | AMERICAN REGENT, INC. | 2020-07-09 | — | — | US | disclosed |
| US-20200215097-A1 | METHODS AND COMPOSITIONS FOR ADMINSTRATION OF IRON | AMERICAN REGENT, INC. | 2020-07-09 | — | — | US | disclosed |
| US-10478450-B2 | Methods and compositions for administration of iron | LUITPOLD PHARMACEUTICALS, INC. (US) | 2019-11-19 | — | — | US | disclosed |
| US-20190328771-A1 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | LUITPOLD PHARMACEUTICALS, INC. | 2019-10-31 | — | — | US | disclosed |
| US-10434118-B2 | — | — | 2019-10-08 | — | — | US | disclosed |
| US-10391117-B2 | — | — | 2019-08-27 | — | — | US | disclosed |
| US-10314856-B2 | — | — | 2019-06-11 | — | — | US | disclosed |
| US-8895612-B2 | Methods and compositions for administration of iron | LUITPOLD PHARMACEUTICALS, INC. (US) | 2014-11-25 | — | — | US | disclosed |
| US-20140099381-A1 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | LUITPOLD PHARMACEUTICALS, INC. (US) | 2014-04-10 | — | — | US | disclosed |
| US-20130230565-A1 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | LUITPOLD PHARMACEUTICALS, INC. (US) | 2013-09-05 | — | — | US | disclosed |
| EP-2626074-A1 | Methods and compositions for administration of iron | Luitpold Pharmaceuticals, Inc. (US) | 2013-08-14 | — | — | EP | disclosed |
| US-8431549-B2 | Methods and compositions for administration of iron | LUITPOLD PHARMACEUTICALS, INC. (US) | 2013-04-30 | — | — | US | disclosed |
| US-20100266644-A1 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | LUITPOLD PHARMACEUTICALS, INC. (US) | 2010-10-21 | — | — | US | disclosed |
| US-7754702-B2 | complexed with iron; bioavailability; anemia | LUITPOLD PHARMACEUTICALS, INC. (US) | 2010-07-13 | — | — | US | disclosed |
| EP-1973549-A2 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | Luitpold Pharmaceuticals, Inc. (US) | 2008-10-01 | — | — | EP | disclosed |
| WO-2007081744-A2 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | LUITPOLD PHARMACEUTICALS, INC. (US) | 2007-07-19 | — | — | WO | disclosed |
| US-20070161600-A1 | complexed with iron; bioavailability; anemia | LUITPOLD PHARMACEUTICALS, INC. (US) | 2007-07-12 | — | — | US | disclosed |